Literature DB >> 21789718

Two possible mechanisms of epithelial to mesenchymal transition in invasive ductal breast cancer.

Sylvie Dubois-Marshall1, Jeremy S Thomas, Dana Faratian, David J Harrison, Elad Katz.   

Abstract

Epithelial to mesenchymal transition (EMT) occurs in embryogenesis and normal development. It has been predominantly described in vitro and in animal studies, but EMT is also implicated in the progression of many cancers with proposed roles in invasion, metastasis and resistance to treatment. It is closely associated with loss of epithelial-specific protein expression and up-regulation of mesenchymal proteins, but several pathways are implicated in its execution. We explored what are the expression patterns of EMT proteins in human breast cancer. We interrogated two independent cohorts enriched for high-grade, invasive, ductal breast cancers. We used quantitative immunofluorescence to study the expression of key EMT proteins. Statistical associations to define protein profiles were based on Pearson's correlations. E-cadherin down-regulation in breast cancer was associated with β-catenin down-regulation, but not with up-regulation of mesenchymal markers. While EMT-related transcription repressors were expressed in some breast cancers, their expression did not negatively correlate with E-cadherin. Instead, an additional EMT profile was identified, composing Snail and Slug. In conclusion, EMT occurs in human breast cancer in a manner distinct to that seen in vitro. Certain EMT events are uncoupled from E-cadherin down-regulation and may constitute a novel EMT profile, which warrants further exploration.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21789718     DOI: 10.1007/s10585-011-9412-x

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  38 in total

1.  Twist overexpression induces in vivo angiogenesis and correlates with chromosomal instability in breast cancer.

Authors:  Yelena Mironchik; Paul T Winnard; Farhad Vesuna; Yoshinori Kato; Flonne Wildes; Arvind P Pathak; Scott Kominsky; Dmitri Artemov; Zaver Bhujwalla; Paul Van Diest; Horst Burger; Carlotta Glackin; Venu Raman
Journal:  Cancer Res       Date:  2005-12-01       Impact factor: 12.701

Review 2.  Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?

Authors:  Héctor Peinado; David Olmeda; Amparo Cano
Journal:  Nat Rev Cancer       Date:  2007-05-17       Impact factor: 60.716

Review 3.  Epithelial-mesenchymal transitions in development and disease.

Authors:  Jean Paul Thiery; Hervé Acloque; Ruby Y J Huang; M Angela Nieto
Journal:  Cell       Date:  2009-11-25       Impact factor: 41.582

Review 4.  Molecular requirements for epithelial-mesenchymal transition during tumor progression.

Authors:  Margit A Huber; Norbert Kraut; Hartmut Beug
Journal:  Curr Opin Cell Biol       Date:  2005-10       Impact factor: 8.382

5.  Traditional and new prognosticators in breast cancer: Nottingham index, Mib-1 and estrogen receptor signaling remain the best predictors of relapse and survival in a series of 289 cases.

Authors:  Tiziana Megha; Alessandro Neri; Valeria Malagnino; Stefano Caruso; Monica Onorati; Franco Roviello; Piero Tosi
Journal:  Cancer Biol Ther       Date:  2009-12-22       Impact factor: 4.742

Review 6.  Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis.

Authors:  Jason J Christiansen; Ayyappan K Rajasekaran
Journal:  Cancer Res       Date:  2006-09-01       Impact factor: 12.701

Review 7.  Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits.

Authors:  Kornelia Polyak; Robert A Weinberg
Journal:  Nat Rev Cancer       Date:  2009-03-05       Impact factor: 60.716

Review 8.  Epithelial-mesenchymal transition: a cancer researcher's conceptual friend and foe.

Authors:  Michael W Klymkowsky; Pierre Savagner
Journal:  Am J Pathol       Date:  2009-03-26       Impact factor: 4.307

Review 9.  Cadherin switch in tumor progression.

Authors:  Rachel B Hazan; Rui Qiao; Rinat Keren; Ines Badano; Kimita Suyama
Journal:  Ann N Y Acad Sci       Date:  2004-04       Impact factor: 5.691

10.  A gene on the HER2 amplicon, C35, is an oncogene in breast cancer whose actions are prevented by inhibition of Syk.

Authors:  E Katz; S Dubois-Marshall; A H Sims; D Faratian; J Li; E S Smith; J A Quinn; M Edward; R R Meehan; E E Evans; S P Langdon; D J Harrison
Journal:  Br J Cancer       Date:  2010-07-13       Impact factor: 7.640

View more
  17 in total

1.  SNAIL is induced by tamoxifen and leads to growth inhibition in invasive lobular breast carcinoma.

Authors:  Emily A Bossart; Nilgun Tasdemir; Matthew J Sikora; Amir Bahreini; Kevin M Levine; Jian Chen; Ahmed Basudan; Britta M Jacobsen; Timothy F Burns; Steffi Oesterreich
Journal:  Breast Cancer Res Treat       Date:  2019-02-23       Impact factor: 4.872

2.  Lipocalin-2 is associated with a good prognosis and reversing epithelial-to-mesenchymal transition in pancreatic cancer.

Authors:  Bin Xu; Da-Yong Jin; Wen-Hui Lou; Dan-Song Wang
Journal:  World J Surg       Date:  2013-08       Impact factor: 3.352

3.  Keratinocyte growth factor and thiazolidinediones and linolenic acid differentiate characterized mammary fat pad adipose stem cells isolated from prepubertal Korean black goat to epithelial and adipogenic lineage.

Authors:  A M M T Reza; S Shiwani; N K Singh; J D Lohakare; S J Lee; D K Jeong; J Y Han; D Rengaraj; B W Lee
Journal:  In Vitro Cell Dev Biol Anim       Date:  2013-10-08       Impact factor: 2.416

4.  Three-Dimensional Breast Cancer Models Mimic Hallmarks of Size-Induced Tumor Progression.

Authors:  Manjulata Singh; Shilpaa Mukundan; Maria Jaramillo; Steffi Oesterreich; Shilpa Sant
Journal:  Cancer Res       Date:  2016-05-23       Impact factor: 12.701

Review 5.  The role and function of cadherins in the mammary gland.

Authors:  Jennifer L Andrews; Alvin C Kim; Julie R Hens
Journal:  Breast Cancer Res       Date:  2012-02-08       Impact factor: 6.466

6.  Targeting of Rac GTPases blocks the spread of intact human breast cancer.

Authors:  Elad Katz; Andrew H Sims; Duncan Sproul; Helen Caldwell; Michael J Dixon; Richard R Meehan; David J Harrison
Journal:  Oncotarget       Date:  2012-06

Review 7.  Breast cancer epithelial-to-mesenchymal transition: examining the functional consequences of plasticity.

Authors:  David J Drasin; Tyler P Robin; Heide L Ford
Journal:  Breast Cancer Res       Date:  2011-11-01       Impact factor: 6.466

8.  miR-506 regulates epithelial mesenchymal transition in breast cancer cell lines.

Authors:  Himanshu Arora; Rehana Qureshi; Woong-Yang Park
Journal:  PLoS One       Date:  2013-05-22       Impact factor: 3.240

9.  TMA Navigator: Network inference, patient stratification and survival analysis with tissue microarray data.

Authors:  Alexander L R Lubbock; Elad Katz; David J Harrison; Ian M Overton
Journal:  Nucleic Acids Res       Date:  2013-06-12       Impact factor: 16.971

10.  Dynamic transcription factor networks in epithelial-mesenchymal transition in breast cancer models.

Authors:  Anaar Siletz; Michael Schnabel; Ekaterina Kniazeva; Andrew J Schumacher; Seungjin Shin; Jacqueline S Jeruss; Lonnie D Shea
Journal:  PLoS One       Date:  2013-04-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.